Lecturer Dr. Asad Alipharmaceutical scientist at TIUS specializing in nanotechnology-based drug delivery systems, intranasal brain targeting, and advanced formulation developmentKeynote Speech Title: Transforming Modern Therapeutics: The Expanding Role of Nanoparticle-Based Drug Delivery Systems
Dr. Asad education, Bachelor of Pharmacy (B.Pharm) – 2014 to 2018, Post Graduate Diploma in Regulatory Affairs (PGDRA) – 2019, Master of Pharmacy (M.Pharm) (Pharmaceutics) – 2018 to 2020, Ph.D. in Pharmaceutical Sciences (Pharmaceutics) – December 2020 to May 2025 Department of Pharmaceutics School of Pharmaceutical Education and Research (SPER) Jamia Hamdard, New Delhi, India
Thesis: Fluoxetine and Embelin Loaded Intranasal Thermosensitive Nanoliposomes for Management of Depression.
His research interests include nanoliposomes, nanostructured lipid carriers, transferosomes, transethosomes, microneedle-based transdermal systems, thermosensitive in situ gels, quality by design (QbD)-based formulation optimization, intranasal brain targeting, and nano-theragnostic. He has strong expertise in nano formulation development, analytical characterization (HPLC, UV spectroscopy, DLS, DSC, FTIR, XRD), in vitro and in vivo evaluation, regulatory guidelines (ICH, USFDA, EMA), and pharmaceutical documentation.